- Record: found
- Abstract: found
- Article: not found
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
G Greub
1 ,
B Ledergerber ,
M Battegay ,
P Grob ,
L Perrin ,
H Furrer ,
P Burgisser ,
P Erb ,
K Boggian ,
J C Piffaretti ,
B Hirschel ,
P Janin ,
P Francioli ,
M Flepp ,
A Telenti
Nov 25 2000
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Hepatitis C virus (HCV) infection is highly prevalent among HIV-1-infected individuals, but its contribution to the morbidity and mortality of coinfected patients who receive potent antiretroviral therapy is controversial. We used data from the ongoing Swiss HIV Cohort Study to analyse clinical progression of HIV-1, and the virological and immunological response to potent antiretroviral therapy in HIV-1-infected patients with or without concurrent HCV infection.